EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanoparticle Drug Delivery Systems for Atherosclerosis: Precision Targeting, Inflammatory Modulation, and Plaque Stabilization

Yunqi Zhang iD, Feifei Li, Libo Liu, Ziyu An, Hanzhong Luo, Huan Zhang, Rui Ma, Ruoxi Zhang, Qiong Dai, Mingduo Zhang, Jinfan Tian, Chaoyong Liu und 2 weitere

Advanced Science · 2025-09 · 12 (36)

DOI: 10.1002/advs.202504990 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 28.08.2025. Verfasst von Yunqi Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, P. R. China. Hauptthemen laut MEDLINE: Atherosclerosis, Plaque, Atherosclerotic, Drug Delivery Systems, Nanoparticle Drug Delivery System. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Anzhen Hospital High Level Research Funding, Beijing Municipal Association for Science and Technology Young Talent Promotion Project, Beijing Hospitals Authority's Ascent Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis remains a leading contributor to cardiovascular morbidity and mortality, presenting considerable therapeutic challenges due to its multifaceted and complex pathogenesis. This review systematically explores the pathophysiological mechanisms underlying atherosclerosis and examines recent advances in nanoparticle drug delivery systems (NDDSs) tailored for atherosclerosis treatment. NDDS has many advantages in this setting. It can precisely modulate the cellular activities critical to atherosclerotic progression, and by using targeted delivery strategies directed at lesion‐specific biomarkers and incorporating stimulus‐responsive drug release mechanisms responsive to the plaque microenvironments, it can significantly increase therapeutic efficacy while minimizing adverse systemic and off‐target effects. Thus, NDDS effectively addresses the limitations of traditional pharmacological treatments, enabling personalized interventions that can attenuate disease progression, stabilize vulnerable plaques, and facilitate plaque regression. This review highlights the transformative possibilities of NDDSs, emphasizing their potential to redefine current therapeutic paradigms and improve patient outcomes in atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisPlaque, AtheroscleroticDrug Delivery SystemsNanoparticle Drug Delivery SystemInflammationNanoparticlesHumansAnimals

Stichwörter der Autor:innen

atherosclerosisdrug deliverynanomedicinenanoparticles

Substanzen

Nanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, P. R. China.
  • State Key Laboratory of Organic-Inorganic Composites, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijin…

ORCID-Profile: Yunqi Zhang, Xiantao Song

Förderung

  • Beijing Anzhen Hospital High Level Research Funding
  • Beijing Municipal Association for Science and Technology Young Talent Promotion Project
  • Beijing Hospitals Authority's Ascent Plan
  • High-level public health technical talent construction project of Beijing Municipal Health Commission (Leading Talent-02-01)
  • Scientific and Technological Development Fund of Beijing Anzhen Hospital

Zitieren

APA

Zhang, Y., Li, F., Liu, L., An, Z., Luo, H., Zhang, H., Ma, R., Zhang, R., Dai, Q., Zhang, M., Tian, J., Liu, C., Song, X., & Lu, Y. (2025). Nanoparticle Drug Delivery Systems for Atherosclerosis: Precision Targeting, Inflammatory Modulation, and Plaque Stabilization. Advanced Science, 12(36). https://doi.org/10.1002/advs.202504990

Vancouver

Zhang Y, Li F, Liu L, An Z, Luo H, Zhang H, et al. Nanoparticle Drug Delivery Systems for Atherosclerosis: Precision Targeting, Inflammatory Modulation, and Plaque Stabilization. Advanced Science. 2025;12(36). doi:10.1002/advs.202504990

BibTeX
@article{Zhang2025,
  author = {Zhang, Yunqi and Li, Feifei and Liu, Libo and An, Ziyu and Luo, Hanzhong and Zhang, Huan and Ma, Rui and Zhang, Ruoxi and Dai, Qiong and Zhang, Mingduo and Tian, Jinfan and Liu, Chaoyong and Song, Xiantao and Lu, Yunfeng},
  title = {Nanoparticle Drug Delivery Systems for Atherosclerosis: Precision Targeting, Inflammatory Modulation, and Plaque Stabilization},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {36},
  doi = {10.1002/advs.202504990}
}
Kostenlos starten →